Abstract

lntroduction: Erythema multiforme (EM) is an acute inflammatory hypersensitivity reaction of skin

and mucous membranes that usually develop due to infections and drugs and can be seen in all

age groups. Few studies has been reported in chilhood. in this study we aimed to evaluate the

patientswith EM in ourclinic.

Material And Method: 16 patients who were hospitalized with diagnosis of EM between July

2003-June 2004 were evaluated retrospectively in terms of clinical findings, etiology, treatment

and prognosis.

Results and Discussion: Eleven mele ( 68.8%) and 5 female patient were enrolled and the age

renge was between 8 months -16 years (mean 5.7 years c 53. l month). While the lesions were

limited to the skin in 81.2% of the patients, mucosal involvement was accompanied in 18.8% of

the patients. Underlying etiological factors of EM were mastly infections followed by drugs and

vaccination in only one patient. However, ın 18.8% of the patients, no definitive cause was

determined. Skin biopsies were teken in 3 patients with suspicious lesions. Pathological

examinations revealed EM, leukocytoclastic vasculitis and superficial perivascular dermatitis

respectively in these patients. While all patients received systemic antihistaminic, 9 of them were

given steroid and five were given clarithromyein additionally.

it is sometimes difficult to determine the etiology of EM in pediatric patients because of infections

and drug usage at the seme time. Skin biopsy may be done in patients with uncertain lesi ons forthe

differential diagnosis of EM. Although steroid therapy is stili debated in treatment of EM, it may be

useful in the treatment of severe patients.

Keywords: Childhood, etiology, erythema multiforme.

References

  1. 1. Lcautc-Labrezc C, Lamircau T, Clıawki D, Mal.evill.e J, Tai.eb A. Diagnosis, clııssifıcation and ınanag-ement of erythema multiforme and
  2. StevensJohnsonsyndrome.ArchDisClıild2000;83:347-352.
  3. 2. Ukşal Ü. Çocuklarda görülen ilaç dök:üntiikri. Tütk DermatolojiDcrgisi2007; 1: 15-20.
  4. 3. Akman A, Alpsoy E. Eritcma Multiforme, St.even- Johnson Sendromu Ve Toksik Epidermal Nekroli.z (lycll Sendromu). Türkiye Klnikkri.Acil TıpDergisi.2006; 2: 6-15.
  5. 4. Roujcau JC. Whatis going on in erythcma multiforme? Dcrmatology
  6. 1994; 1884:249-250.
  7. 5. Morclli JG. Erythema Multifurmc. In: Klicgman RM, Bchrman RE,
  8. Jcnson HB, Stanton BF{cds): N el.son Tcxtbookof Pcdiattics, 18th cd.
  9. Philadclphia2007: 2685-2687.
  10. 6. Forman R, Korcn G, Shear NH. Erythema multifomıe, St:evcn Johnson Syndrome and tmic epidemw necrolysis in children: a
  11. reviewof 10 ycar's expcricncc. Drugsafcty2002; 13: 965-972.
  12. 7. Kaur S, Handa S. Brythema multiforme followiııg vaccirultion in an
  13. infant. Indian) Dermatol VenereolLeprol 2008; 74: 251-253.
  14. 8. SerdaroğluS, Uysal S. Eritema multiforme. Dermatose 2002; 1: 9-15.
  15. 9. Al-Johani KA, Fedele S, Parter SR. Erythema multiforme and related
  16. disorden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;
  17. 103: 642-654.
  18. 10. Weston WL, Morelli JG, Rogeı:s M. Taı:get lesions on the lips, childhood hcrpcs simplc:x associated with crythcma multiforme mimics
  19. Steven Johnson syndrome. J Am Acad Dermatol 1997; 37: 848-850.
  20. 11. Kalrourou T, KlontzaD, Soteropoulou F, Katwnis C. Corticosteroid
  21. ttcatmcnt of crythema multiformc major (Stcvcns-Johnson syndrome) in children. Eur J Pediatr 1997; 156: 90-93.
  22. U. Rasmussen JE. Brythema multiforme in ehi !dren. Rcsponsc to ttcatment with syııtemic corticosteroids. Br J Dermatol 1976; 9 5: 181-186.

How to cite

1.
Kondolot M, Çipe F, Özmen S, Arslan Z. EVALUATION OF CASES WITH ERYTHEMAMULTIFORME. Turk J Pediatr Dis [Internet]. 2008 Apr. 1 [cited 2025 Aug. 23];2(3):5-10. Available from: https://turkjpediatrdis.org/article/view/39